Evalve out of Menlo Park, California has enrolled the first patients in a study called REALISM, Real World ExpAnded MuLtIcenter Study of the MitraClip® System, that will assess the effectiveness of the company’s MitraClip™ percutaneous device, thought to be a possible treatment for mitral regurgitation. The study will be comparing MitraClip™ to mitral valve surgery.
Here’s a well produced animation demonstrating how the MitraClip is introduced into the heart:
Device page: MitraClip
More details about the trial, in the press release: FIRST U.S. PATIENTS ENROLLED IN THE REALISM CONTINUED ACCESS STUDY
Flashbacks: The MitraClip™